SZ 343 (Ondansetron Orally Disintegrating 8 mg)
Pill imprint SZ 343 has been identified as Ondansetron hydrochloride (orally disintegrating) 8 mg.
Ondansetron is used in the treatment of nausea/vomiting; gastroenteritis; alcohol dependence; obsessive compulsive disorder; nausea/vomiting, chemotherapy induced (and more), and belongs to the drug class 5HT3 receptor antagonists. There is no proven risk in humans during pregnancy. Ondansetron 8 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for SZ 343
- 8 mg
- 7.00 mm
- Prescription only
- Drug Class:
- 5HT3 receptor antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
silicon dioxide colloidal
sodium starch glycolate type A potato
|NDC Code||Manufacturer / Repackager|
|54569-6124||A S Medication Solutions LLC (repackager)|
|21695-0479||Rebel Distributors Corp (repackager)|
Note: Inactive ingredients may vary.
More about ondansetron
- Ondansetron orally disintegrating tablets
- Ondansetron soluble film
- Ondansetron solution
- Ondansetron tablets
- More (3) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.